Finasteride 1mg is an FDA-approved oral medication for androgenetic alopecia (male-pattern hair loss) in men. This article provides an educational overview of how finasteride works, what the clinical research has examined, and what patients should understand before consulting with a provider.
Androgenetic alopecia in men is associated with the androgen dihydrotestosterone (DHT). DHT is converted from testosterone by the enzyme 5-alpha reductase. In genetically predisposed individuals, DHT is associated with hair follicle miniaturization — a gradual shortening of the active hair growth phase. Finasteride is a selective 5-alpha reductase inhibitor that reduces circulating DHT levels, which is its established mechanism for androgenetic alopecia treatment in men.
Finasteride 1mg (brand name Propecia) has been studied in randomized, placebo-controlled clinical trials in men with androgenetic alopecia. These studies examined changes in hair counts and clinical assessment of scalp coverage over defined follow-up periods. Individual patient results vary significantly. Outcomes observed in clinical trials reflect averages across studied populations and do not predict any individual patient’s response. Some patients experience no benefit. Finasteride is not a cure for androgenetic alopecia.
Most clinical guidance indicates that meaningful assessment of finasteride’s effect is not possible before 6–12 months of consistent use. Early months of therapy may primarily involve stabilization of ongoing hair loss, if any effect occurs. Discontinuing finasteride is generally associated with resumption of hair loss progression over time. Permanent hair retention is not guaranteed.
Finasteride carries documented risks that patients must review with a provider before starting. These include potential changes to sexual function (libido, ejaculation, erectile function) reported in a subset of clinical trial participants. Post-finasteride syndrome is a reported condition under ongoing research and medical debate. The full risk profile should be reviewed thoroughly with a licensed provider. Finasteride must not be used by women who are pregnant or may become pregnant due to the risk of harm to a developing male fetus.
Oral finasteride is available through Regen Doctors as a prescription product following a telemedicine consultation with a licensed provider. No prescription is issued without a completed provider evaluation. Pricing is confirmed with the patient before any order is processed or shipped. Medication will not be dispensed without prior patient approval.
*Educational Content Notice: This article is for informational purposes only and does not constitute medical advice. Finasteride requires a valid prescription from a licensed provider. Individual results vary and no specific outcome is guaranteed. Not appropriate for women who are pregnant or may become pregnant.
*Important Disclosures: Finasteride requires a valid prescription. A licensed provider consultation is mandatory before dispensing. Individual results vary and no specific outcome is guaranteed. Finasteride is not appropriate for women who are pregnant or may become pregnant. Compounded finasteride is not the same as FDA-approved Propecia; compounded formulations are not FDA-approved. This content does not constitute medical advice.
